These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37046586)

  • 1. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
    Ho SY; Liu PH; Hsu CY; Tseng HT; Huang YH; Su CW; Hou MC; Huo TI
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
    J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
    Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK; Song MJ; Kim SH; Park M
    PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Hansmann J; Evers MJ; Bui JT; Lokken RP; Lipnik AJ; Gaba RC; Ray CE
    J Vasc Interv Radiol; 2017 Sep; 28(9):1224-1231.e2. PubMed ID: 28688815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
    Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Lee YH; Lee RC; Huang YH; Lee FY; Hou MC; Tsai YJ; Huo TI
    PLoS One; 2017; 12(7):e0180408. PubMed ID: 28672011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade.
    Liao JI; Ho SY; Liu PH; Hsu CY; Huang YH; Su CW; Hou MC; Huo TI
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis.
    Oikonomou T; Goulis L; Doumtsis P; Tzoumari T; Akriviadis E; Cholongitas E
    Ann Hepatol; 2019; 18(1):126-136. PubMed ID: 31113581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin ‎grade: ‎ A Preliminary Study.
    Huang Z; Zuo M; Ni J; Gu Y; Zhang T; Jiang Y; Zhuo S; An C; Huang J
    Cancer Manag Res; 2020; 12():1373-1385. PubMed ID: 32158269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To determine the prognostic value of the albumin-bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma.
    Khalid MA; Achakzai IK; Hanif FM; Ahmed S; Majid Z; Luck NH
    Gastroenterol Hepatol Bed Bench; 2019; 12(2):110-115. PubMed ID: 31191834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
    Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
    Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin grade.
    Liao JI; Ho SY; Hou MC; Liu PH; Hsu CY; Huo TI
    J Chin Med Assoc; 2024 Feb; 87(2):156-162. PubMed ID: 38095597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
    [No Abstract]   [Full Text] [Related]  

  • 18. Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery: A retrospective observational study.
    Wu B; Hu X; Jin H; Zhou L; Zhang D; Man Z; Wang Y; Yang S; Pang Q; Liu H; Cui P
    Medicine (Baltimore); 2019 Oct; 98(43):e17394. PubMed ID: 31651841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia.
    Man ZR; Gong XK; Qu KL; Pang Q; Wu BQ
    World J Gastrointest Oncol; 2024 May; 16(5):1763-1772. PubMed ID: 38764822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
    Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.